Sub-Class Code Sub-Classification Other code. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired. Pure red cell aplasia (non
|
|
|
- Job King
- 6 years ago
- Views:
Transcription
1 ification Sub- Sub-ification code Absence of T & B cells SCID 8 Inherited Disorders 1 Primary immune deficiencies Absence of T, normal B cell SCID 8 Inherited Disorders 1 Primary immune deficiencies Acquired cytopenic syndrome 77 1 Acquired Acquired immune deficiency syndrome (HIV infection) 10 Autoimmune Disorders 77 Acquired Pure Red Cell Aplasia (PRCA) Pure red cell aplasia (non 2 PRCA) Acute biphenotypic leukaemia 1 Acute Leukaemia 4 Acute biphenotypic leukaemia Acute leukaemia 1 Acute Leukaemia 1 Acquired Acute leukaemia, secondary to previous MDS diagnosis 1 Myeloproliferative Syndrome Acute leukaemia, secondary to previous MPS diagnosis Acute leukaemia, secondary to treatment of primary disease 1 Acute Leukaemia Acute lymphocytic leukaemia 1 Acute Leukaemia 2 ALL Acute mast cell leukaemia 1 Acute Leukaemia 5 Acute mast cell leukaemia Acute myelofibrosis (Chronic idiopathic myelofibrosis) Acute myeloid leukaemia 1 Acute Leukaemia 1 AML Acute myelosclerosis (Chronic idiopathic myelofibrosis) Acute undifferentiated leukaemia 1 Acute Leukaemia Acute undifferentiated 3 leukaemia EBMT 31/07/2013 Page 1 of 17
2 ification Sub- Sub-ification code ADA deficiency (SCID) 8 Inherited Disorders 1 Primary immune deficiencies Adenocarcinoma origin X 5 Solid Tumours 93 Adenocarcinoma origin X Adenosine deaminase deficiency (SCID) (ADA) 8 Inherited Disorders 1 Primary immune deficiencies Adrenoleukodystrophy 8 Inherited Disorders 2 Disorders of metabolism Adult T-cell lymphoma/leukaemia (HTLV1+) 1 Acute Leukaemia 2 ALL Aggressive NK-cell leukaemia 3 Lymphoma 182 Aggressive NK-cell leukaemia Agranulocytosis (Kostmann) 8 Inherited Disorders 1 Primary immune deficiencies AIDS (HIV infection) 10 Autoimmune Disorders 77 AILD (Angioimmunoblastic lymphoma T-cell) 3 Lymphoma Angioimmunoblastic T-cell 110 (AILD) Albers-Schonberg Disease (Osteopetrosis) 8 Inherited Disorders Osteopetrosis ALL 1 Acute Leukaemia 2 ALL Amegakaryocytosis () Amegakaryocytic thrombocytopaenia 6 () Amegakaryocytic Amegakaryocytosis acquired 5 thrombocytopaenia AML 1 Acute Leukaemia 1 AML Amyloidosis 4 Plasma Cell Disorders 5 Amyloidosis Anaplastic large-cell, T/null Anaplastic large-cell, T/null cell cell types 3 Lymphoma 130 types Anaplastic large-cell, T/null cell, primary cutaneous Anaplastic large-cell, T/null cell, lymphoma 3 Lymphoma 131 primary cutaneous lymphoma Anaplastic large-cell, T/null cell, primary systemic Anaplastic large-cell, T/null cell, lymphoma 3 Lymphoma 132 primary systemic lymphoma Angioimmunoblastic Angioimmunoblastic T-cell lymphoma T-cell (AILD) 3 Lymphoma 110 (AILD) Angiosarcoma 5 Solid Tumours 68 Angiosarcoma 2 Congenital 1 Acquired EBMT 31/07/2013 Page 2 of 17
3 ification Sub- Sub-ification code Antiphospholipid syndrome 10 Autoimmune Disorders 1 Connective Tissue Disease Aplastic anaemia 1 Aplastic anaemia 1 Acquired Aspartyl glucosaminuria 8 Inherited Disorders 2 Disorders of metabolism Astrocytoma 5 Solid Tumours 21 Astrocytoma Ataxia telangiectasia 8 Inherited Disorders 1 Primary immune deficiencies Atypic Hairy Cell Leukaemia 2 Chronic Leukaemia Chronic lymphocytic 77 leukaemia Atypic Hairy Cell 4 Leukaemia Autoimmune diseases 10 Autoimmune Disorders 77 Autoimmune diseases 10 Autoimmune Disorders Bare lymphocyte/lack of HLAantig xp 8 Inherited Disorders 1 Primary immune deficiencies Batten disease (Neuronal ceriod lipofuscinosis) 8 Inherited Disorders 2 Disorders of metabolism B-Cell / Small Lymphocytic Leukaemia 2 Chronic Leukaemia 2 Chronic lymphocytic leukaemia B-cell lymphomas (NHL), unspecified 3 Lymphoma B-CELL lymphomas (NHL), 5 unspecified Behçet s syndrome 10 Autoimmune Disorders 2 Vasculitis Berlin breakage syndrome 8 Inherited Disorders 1 Primary immune deficiencies 57 CID B-glucuronidase deficiency (VII) 8 Inherited Disorders 2 Disorders of metabolism Blast NK cell 3 Lymphoma 145 Blast NK cell Bone sarcoma (exclude Ewing sarcoma, include PNET sarcoma) 5 Solid Tumours 10 Bone sarcoma Breast Cancer (Inflammatory / Non inflammatory) 5 Solid Tumours 80 Breast cancer Burkitt cell leukemia 3 Lymphoma Burkitt lymphoma / Burkitt cell 50 leukaemia & variants Burkitt s lymphoma 3 Lymphoma Burkitt lymphoma / Burkitt cell 50 leukaemia & variants EBMT 31/07/2013 Page 3 of 17
4 ification Sub- Sub-ification code Cartilage hair hypoplasia 8 Inherited Disorders 1 Primary immune deficiencies Castleman's disease 3 Lymphoma 301 Castleman's disease CD40 ligand deficiency 8 Inherited Disorders 1 Primary immune deficiencies Central nervous system (include CNS PNET) 5 Solid Tumours 777 Chediak-Higashi syndrome 8 Inherited Disorders 1 Primary immune deficiencies Choriocarcinoma 5 Solid Tumours 46 Choriocarcinoma Chronic eosinophylic leukaemia Chronic granulomatous disease 8 Inherited Disorders 1 Primary immune deficiencies Chronic idiopathic myelofibrosis Chronic leukaemia 2 Chronic leukaemia Chronic lymphocytic leukaemia 2 Chronic Leukaemia 2 Chronic lymphocytic leukaemia Chronic myeloid leukaemia 2 Chronic Leukaemia 1 Chronic myeloid leukaemia Chronic myelomonocytic leukaemia 4 Myeloproliferative Syndrome Churg-Strauss 10 Autoimmune Disorders 2 Vasculitis CID 8 Inherited Disorders 1 Primary immune deficiencies CID with Ig 8 Inherited Disorders 1 Primary immune deficiencies CID with Immunoglobulins (CID with Ig) 8 Inherited Disorders 1 Primary immune deficiencies CLL 2 Chronic Leukaemia 2 Chronic lymphocytic leukaemia CLL, T-cell 2 Chronic Leukaemia 2 Chronic lymphocytic leukaemia EBMT 31/07/2013 Page 4 of 17
5 ification Sub- Sub-ification code CML 2 Chronic Leukaemia 1 Chronic myeloid leukaemia CMML (Chronic myelomonocytic leukaemia) 4 Myeloproliferative Syndrome CMMoL (Chronic myelomonocytic leukaemia) 4 Myeloproliferative Syndrome CNS tumours 5 Solid Tumours 777 Colon adenocarcinoma 5 Solid Tumours 96 Colon adenocarcinoma Combined immune deficiency 8 Inherited Disorders 1 Primary immune deficiencies Combined myelodysplastic & myeloproliferative syndromes 4 Myeloproliferative Syndrome Common variable immunodeficiency (CID) 8 Inherited Disorders 1 Primary immune deficiencies Congenital amegakaryocytosis Amegakaryocytic thrombocytopaenia 5 () Congenital neutropaenia (Kostmann syndrome) 8 Inherited Disorders 1 Primary immune deficiencies Diamond-Blackfan ( Congenital PRCA 2 PRCA) Crohn s disease 10 Autoimmune Disorders 7 Bowel Crow-Fukase syndrome (POEMS) 4 Plasma Cell Disorders 6 POEMS Cytopaenia 10 Autoimmune Disorders 6 Haematological Dermatomyositis 10 Autoimmune Disorders 1 Connective Tissue Disease Di George anomaly 8 Inherited Disorders 1 Primary immune deficiencies Diamond-Blackfan anaemia Diamond-Blackfan ( 2 PRCA) Diffuse large B-cell Diffuse large B-cell (including lymphoma 3 Lymphoma 40 mediastinal) 2 Congenital 2 Congenital 2 Congenital EBMT 31/07/2013 Page 5 of 17
6 ification Sub- Sub-ification code Duncan syndrome (X-linked lymphoproliferative syndrome) 8 Inherited Disorders 1 Primary immune deficiencies Dyserythropoietic anaemia 4 Dyserythropoietic anaemia 2 Congenital Dyskeratosis congenita 5 Dyskeratosis congenita 2 Congenital Dyskeratosis congenita 8 Inherited Disorders 1 Primary immune deficiencies Embryonal carcinoma 5 Solid Tumours 42 Embryonal carcinoma Enteropathy-type T-cell lymphoma 3 Lymphoma 160 Enteropathy type T-cell Ependymoma 5 Solid Tumours 24 Ependymoma Erythrophagocytic lympohystiocytosis/hemoph agocytosis 9 Histiocytic disorders Familial erythro/hemophagocytic 1 lymphohistiocyto Evan syndrome 10 Autoimmune Disorders 6 Haematological Ewing sarcoma 5 Solid Tumours 31 Ewing`s sarcoma Extranodal marginal zone of MALT type lymphoma 3 Lymphoma Extranodal marginal zone B-cell 30 of MALT type Extranodal NK/T-cell lymphoma, nasal type 3 Lymphoma 150 Extranodal NK/T-cell, nasal type Familial erythro/hemophagocytic lymphohistiocytosis (FELH) 9 Histiocytic disorders Familial erythro/hemophagocytic 1 lymphohistiocyto Familial reticuloendotheliosis (Omenn's syndrome) 8 Inherited Disorders 1 Primary immune deficiencies Fanconi anaemia 1 Fanconi 2 Congenital FELH / FLH (Familial erythro Familial / hemophagocytic erythro/hemophagocytic lymphohistiocytosis) 9 Histiocytic disorders 1 lymphohistiocyto EBMT 31/07/2013 Page 6 of 17
7 ification Sub- Sub-ification code FHLH (Familial hemophagocytic lymphohistiocytosis) 9 Histiocytic disorders Familial erythro/hemophagocytic 1 lymphohistiocyto Fibrosarcoma 5 Solid Tumours 66 Fibrosarcoma Follicular dendritic sarcoma 9 Histiocytic disorders 77 Follicular lymphoma 3 Lymphoma 10 Follicular lymphoma Fucosidosis 8 Inherited Disorders 2 Disorders of metabolism Gastric carcinoma + adenocarcinoma 5 Solid Tumours Gastric carcinoma + 92 adenocarcinoma Gaucher disease 8 Inherited Disorders 2 Disorders of metabolism Genetic agranulocytosis (Kostmann syndrome) 8 Inherited Disorders 1 Primary immune deficiencies Germ cell tumour 5 Solid Tumours 40 Germ cell tumour Giant cell arteritis 10 Autoimmune Disorders 2 Vasculitis Glanzmann thrombasthenia 8 Inherited Disorders 77 Glioblastoma 5 Solid Tumours 23 Glioblastoma Globoid leukodystrophy (Krabbe disease) 8 Inherited Disorders 2 Disorders of metabolism Glucose storage disease 8 Inherited Disorders 2 Disorders of metabolism Granulocytic sarcoma 1 Acute Leukaemia 6 Granulocytic sarcoma Griscelli syndrome 8 Inherited Disorders 1 Primary immune deficiencies Haemoglobinopathy, heterozygous 11 Haemoglobinopathy 6 Compound heterozygous state Hairy Cell Leukaemia 2 Chronic Leukaemia Chronic lymphocytic 77 leukaemia 77 leukaemia Hairy Cell Leukaemia 2 Chronic Leukaemia Chronic lymphocytic 77 leukaemia Hairy cell 3 leukaemia Hairy cell leukaemia 2 Chronic Leukaemia Chronic lymphocytic 77 leukaemia Hairy cell 3 leukaemia Hairy Cell Leukaemia, atypic 2 Chronic Leukaemia Chronic lymphocytic 77 leukaemia Atypic Hairy Cell 4 Leukaemia Hemangiosarcoma 5 Solid Tumours 69 Haemangiosarcoma Hemolytic anemia, acquired 10 Autoimmune Disorders 6 Haematological EBMT 31/07/2013 Page 7 of 17
8 ification Sub- Sub-ification code Hemolytic anemia, 77 2 Congenital Hemolytic anemia, not 10 Autoimmune Disorders 6 Haematological Hemophagocytosis (reactive or viral associated) 9 Histiocytic disorders Hemophagocytosis (reactive or 3 viral associated) Hepatosplenic gamma-delta T-cell lymphoma 3 Lymphoma Hepatosplenic gamma-delta T- 170 cell HGPRT deficiency (Lesch- Nyhan) 8 Inherited Disorders 2 Disorders of metabolism Histiocytic and dendritic cell neoplasm 9 Histiocytic disorders 77 Histiocytic dsorders 9 Histiocytic disorders Histiocytic sarcoma 9 Histiocytic disorders 4 Malignant histiocytosis Histiocytosis X (Langerhans Cell Histiocytosis) 9 Histiocytic disorders Langerhans Cell Histiocytosis 2 (Histiocytosis-X) HIV infection 10 Autoimmune Disorders 77 Hodgkins 3 Lymphoma 200 Hodgkins HTLV1+ 1 Acute Leukaemia 2 ALL Hunter syndrome (II) 8 Inherited Disorders 2 Disorders of metabolism Hurler / Scheie syndrome 8 Inherited Disorders 2 Disorders of metabolism Hurler syndrome (IH 8 Inherited Disorders 2 Disorders of metabolism Hyper eosinophilic syndrome Hyper IgM syndrome (CD40 ligand deficiency) 8 Inherited Disorders 1 Primary immune deficiencies I-cell disease 8 Inherited Disorders 2 Disorders of metabolism Idiopathic thrombocytopenic purpura (ITP) 10 Autoimmune Disorders 6 Haematological IL-7R alpha deficiency 8 Inherited Disorders 1 Primary immune deficiencies Immune deficiencies (primary) 8 Inherited Disorders 1 Primary immune deficiencies EBMT 31/07/2013 Page 8 of 17
9 ification Sub- Sub-ification code Immune deficiency with increased IgM (CD40 ligand deficiency) 8 Inherited Disorders 1 Primary immune deficiencies Inborn errors (except BMF) 8 Inherited Disorders Inborn errors of metabolism 8 Inherited Disorders 2 Inborn errors of metabolism Inflammatory breast cancer 5 Solid Tumours 80 Breast cancer Inherited disorders (except BMF) 8 Inherited Disorders Interferon gamma receptor deficiency 8 Inherited Disorders 1 Primary immune deficiencies ITP (Idiopathic thrombocytopenic purpura) 10 Autoimmune Disorders 6 Haematological JAK3 deficiency 8 Inherited Disorders 1 Primary immune deficiencies JCML (Juvenile myelomonocytic leukaemia) 4 Myeloproliferative Syndrome JCMML (Juvenile myelomonocytic leukaemia) 4 Myeloproliferative Syndrome JIA (Juvenile idiopathic arthritis) 10 Autoimmune Disorders 3 Arthritis JMML (Juvenile myelomonocytic leukaemia) 4 Myeloproliferative Syndrome Juvenile idiopathic arthritis (JIA) 10 Autoimmune Disorders 3 Arthritis Juvenile myelomonocytic leukaemia 4 Myeloproliferative Syndrome Kahler disease 4 Plasma Cell Disorders 1 Multiple myeloma Kidney tumour (non Wilms) 5 Solid Tumours 99 kidney tumour EBMT 31/07/2013 Page 9 of 17
10 ification Sub- Sub-ification code Kostmann syndrome 8 Inherited Disorders 1 Primary immune deficiencies Krabbe disease (globoid leukodystrophy) 8 Inherited Disorders 2 Disorders of metabolism LAD (Leukocyte adhesion deficiency) 8 Inherited Disorders 1 Primary immune deficiencies Langerhans Cell Histiocytosis (Histiocytosis-X) 9 Histiocytic disorders Langerhans Cell Histiocytosis 2 (Histiocytosis-X) Leiomyosarcoma 5 Solid Tumours 63 Leiomyosarcoma Lennert lymphoma 3 Lymphoma 120 Peripheral T-cell Lennert variant Lesch-Nyhan (HGPRT deficiency) 8 Inherited Disorders 2 Disorders of metabolism Leukocyte adhesion deficiency (LAD) 8 Inherited Disorders 1 Primary immune deficiencies LFA deficiency (Leukocyte adhesion deficiency) 8 Inherited Disorders 1 Primary immune deficiencies Liposarcoma 5 Solid Tumours 65 Liposarcoma Louis-Bar Syndrome (Ataxia telangiectasia) 8 Inherited Disorders 1 Primary immune deficiencies Lung cancer, non-small cell 5 Solid Tumours Non-small cell lung cancer 57 (NSCLC) Lung cancer, small cell 5 Solid Tumours 54 Small cell lung cancer (NSCLC) Lymphoma 3 Lymphoma Lymphoplasmacytic lymphoma 3 Lymphoma 70 Lymphoplasmcytic lymphoma Malignant histiocytosis 9 Histiocytic disorders 4 Malignant histiocytosis MALT (Extranodal marginal zone of MALT type lymphoma) 3 Lymphoma Extranodal marginal zone B-cell 30 of MALT type Mannosidosis 8 Inherited Disorders 2 Disorders of metabolism Mantle cell lymphoma 3 Lymphoma 20 Mantle cell lymphoma Marchiafava-Micheli syndrome Paroxysmal nocturnal 3 haemoglobinuria Maroteaux-Lamy (VI) 8 Inherited Disorders 2 Disorders of metabolism 1 Acquired EBMT 31/07/2013 Page 10 of 17
11 ification Sub- Sub-ification code Mastocytosis, systemic 6 Myeloproliferative Syndrome MDS Myelodysplastic Syndromes 1 (MDS) Mediastinal neoplasm 5 Solid Tumours 777 Medulloblastoma 5 Solid Tumours 32 Medulloblastoma Melanoma 5 Solid Tumours 51 Melanoma Metachromatic leukodystrophy 8 Inherited Disorders 2 Disorders of metabolism MHC class II-deficiency 8 Inherited Disorders 1 Primary immune deficiencies Mixed tumour with seminoma 5 Solid Tumours 48 Mixed tumour with seminoma Mixed tumour without seminoma 5 Solid Tumours Mixed tumour without 47 seminoma Morquio (IV) 8 Inherited Disorders 2 Disorders of metabolism MPS (not Mucopolysaccharidosis) MS (Multiple Sclerosis) 10 Autoimmune Disorders 4 Multiple sclerosis Mucolipidoses 8 Inherited Disorders 2 Disorders of metabolism Mucolipidoses II 8 Inherited Disorders 2 Disorders of metabolism Mucopolysaccharidosis 8 Inherited Disorders 2 Disorders of metabolism Multiple myeloma 4 Plasma Cell Disorders 1 Multiple myeloma Multiple Sclerosis (MS) 10 Autoimmune Disorders 4 Multiple sclerosis Myasthenia gravis 10 Autoimmune Disorders 5 neurological Mycosis fungoides 3 Lymphoma 190 Mycosis fungoides Myelodysplastic & myeloproliferative syndromes combined 4 Myeloproliferative Syndrome Myelodysplastic syndrome 6 Myeloproliferative Syndrome 1 Myeloproliferative Syndrome EBMT 31/07/2013 Page 11 of 17
12 ification Sub- Sub-ification code Myelofibrosis with myeloid metaplasia (Chronic idiopathic myelofibrosis) Myeloproliferative syndrome Myelosclerosis (Chronic idiopathic myelofibrosis) Necrotising arteritis 10 Autoimmune Disorders 2 Vasculitis Neuroblastoma 5 Solid Tumours 33 Neuroblastoma Neurogenic sarcoma 5 Solid Tumours 71 Neurogenic sarcoma Neuronal ceriod lipofuscinosis (Batten disease) 8 Inherited Disorders 2 Disorders of metabolism Neutrophil actin deficiency 8 Inherited Disorders 1 Primary immune deficiencies Nezelof syndrome (CID with Ig) 8 Inherited Disorders 1 Primary immune deficiencies NHL (Non Hodgkins Lymphoma) 3 Lymphoma 1 NHL unspecified Niemann-Pick disease 8 Inherited Disorders 2 Disorders of metabolism Nijmegen syndrome 8 Inherited Disorders 1 Primary immune deficiencies 57 CID Nodal marginal zone B-cell lymphoma 3 Lymphoma Nodal marginal zone B-cell (+/- 90 monocytoid B cell) Non Hodgkins Lymphoma, unspecified 3 Lymphoma 1 NHL unspecified Non inflammatory breast cancer 5 Solid Tumours 80 Breast cancer Non-small cell lung cancer 5 Solid Tumours Non-small cell lung cancer 57 (NSCLC) NSCLC 5 Solid Tumours Non-small cell lung cancer 57 (NSCLC) Oligodendroglioma 5 Solid Tumours 22 Oligodendroglioma Omenn's syndrome 8 Inherited Disorders 1 Primary immune deficiencies EBMT 31/07/2013 Page 12 of 17
13 ification Sub- Sub-ification code Osteopetrosis 8 Inherited Disorders Osteopetrosis Osteosarcoma 5 Solid Tumours 11 Osteosarcoma (non Wilms) kidney tumour 5 Solid Tumours 99 kidney tumour gliomas 5 Solid Tumours 25 gliomas Ovarian adenocarcinoma 5 Solid Tumours 49 Ovarian adenocarcinoma Overlapping necrotising arteritis 10 Autoimmune Disorders 2 Vasculitis Paroxysmal nocturnal hemoglobinuria (PNH) Paroxysmal nocturnal 3 haemoglobinuria PEP syndrome (POEMS) 4 Plasma Cell Disorders 6 POEMS Peripheral T-cell 3 Lymphoma 120 Peripheral T-cell Plasma cell disorders 4 Plasma Cell Disorders Plasma cell leukemia 4 Plasma Cell Disorders 2 Plasma cell leukemia Platelet defect, 8 Inherited Disorders 77 Platelet defect, 20 unspecified PLL 2 Chronic Leukaemia Chronic prolymphocytic 3 leukaemia PNET 5 Solid Tumours 30 PNET PNH Paroxysmal nocturnal 3 haemoglobinuria 1 Acquired 1 Acquired PNP- SCID 8 Inherited Disorders 1 Primary immune deficiencies POEMS syndrome 4 Plasma Cell Disorders 6 POEMS Polyarteritis nodosa 10 Autoimmune Disorders 2 Vasculitis Polycythemia vera Polymyositis 10 Autoimmune Disorders 1 Connective Tissue Disease Polysaccharide hydrolase abnormalities 8 Inherited Disorders 2 Disorders of metabolism Post-transplant lymphoproliferative disease 3 Lymphoma Post-transplant 300 lymphoproliferative disease PRCA (acquired) Pure red cell aplasia (non 2 PRCA) 1 Acquired EBMT 31/07/2013 Page 13 of 17
14 ification Sub- Sub-ification code PRCA () Diamond-Blackfan ( 2 PRCA) Pure red cell aplasia (non PRCA (not ) 2 PRCA) 2 Congenital 1 Acquired Precursor B-lymphoblastic Precursor B-cell leukemia/lymphoma 1 Acute Leukaemia 2 ALL 1 lymphoblastic Precursor T-lymphoblastic Precursor T-cell lymphoma/leukemia 1 Acute Leukaemia 2 ALL 11 lymphoblastic Primary amyloidosis 4 Plasma Cell Disorders 5 Amyloidosis Primary immune deficiencies 8 Inherited Disorders 1 Primary immune deficiencies Prolymphocytic Leukaemia 2 Chronic Leukaemia Chronic prolymphocytic 3 leukaemia Prolymphocytic Leukaemia B- cell 2 Chronic Leukaemia Chronic prolymphocytic 3 leukaemia Prolymphocytic Leukaemia T- cell 2 Chronic Leukaemia Chronic prolymphocytic 3 leukaemia Psoriatic arthritis/psoriasis 10 Autoimmune Disorders 3 Arthritis PTLD 3 Lymphoma Post-transplant 300 lymphoproliferative disease Pure red cell, acquired Pure red cell aplasia (non 2 PRCA) 1 Acquired Pure white cell, acquired 4 Pure white cell aplasia 1 Acquired Purine nucleoside phosphorylase deficiency (SCID) (PNP-) 8 Inherited Disorders 1 Primary immune deficiencies Purtilo (X-linked lymphoproliferative syndrome) 8 Inherited Disorders 1 Primary immune deficiencies PWC (acquired) 4 Pure white cell aplasia 1 Acquired PWC (genetic) 77 1 Acquired EBMT 31/07/2013 Page 14 of 17
15 ification Sub- Sub-ification code Pyruvate kinase deficiency resulting in hemolytic anaemia, 77 2 Congenital Rag-1 or Rag-2 8 Inherited Disorders 1 Primary immune deficiencies Refractory anaemia (RA) 6 Myelodysplastic Syndromes Myeloproliferative Syndrome 1 (MDS) Reticular dysgenesis (SCID) 8 Inherited Disorders 1 Primary immune deficiencies Retinoblastoma 5 Solid Tumours 36 Retinoblastoma Rhabdomyosarcoma 5 Solid Tumours 64 Rhabdomyiosarcoma Rheumatoid arthritis 10 Autoimmune Disorders 3 Arthritis Chronic lymphocytic Richter 2 Chronic Leukaemia 77 Sanfilippo (III) 8 Inherited Disorders 2 Disorders of metabolism Sarcoma not otherwise specified 5 Solid Tumours 777 Sarcoma PNET 5 Solid Tumours 30 PNET Scheie syndrome (IS) 8 Inherited Disorders 2 Disorders of metabolism leukaemia 5 SCID 8 Inherited Disorders 1 Primary immune deficiencies SCLC 5 Solid Tumours 54 Small cell lung cancer (SCLC) Scleroderma (Systemic sclerosis) 10 Autoimmune Disorders 1 Connective Tissue Disease Secondary acute leukaemia Myelodysplastic Syndromes after MDS 1 (MDS) Secondary acute leukaemia after MPS Richter's syndrome Secondary acute leukaemia, after treatment of primary disease 1 Acute Leukaemia EBMT 31/07/2013 Page 15 of 17
16 ification Sub- Sub-ification code Seemanova syndrome 8 Inherited Disorders 1 Primary immune deficiencies 57 CID Seminoma 5 Solid Tumours 41 Seminoma Severe combined immune deficiency (SCID) 8 Inherited Disorders 1 Primary immune deficiencies Severe neutropenia (SCN) 8 Inherited Disorders 1 Primary immune deficiencies Sezary syndrome 3 Lymphoma 195 Sezary syndrome Shwachman-Diamond Schwachman-Diamond 3 () Sickle cell disease 11 Haemoglobinopathy 5 Sickle cell anaemia Sjögren syndrome 10 Autoimmune Disorders 1 Connective Tissue Disease SLE (Systemic lupus erythematosus) 10 Autoimmune Disorders 1 Connective Tissue Disease 2 Congenital Small cell lung cancer 5 Solid Tumours 54 Small cell lung cancer (SCLC) Soft tissue sarcoma (include PNET sarcoma) 5 Solid Tumours 60 Soft tissue sarcoma Solid tumour 5 Solid Tumours Solitary plasmacytoma 4 Plasma Cell Disorders 3 Plasmacytoma Sphingolipidoses 8 Inherited Disorders 2 Disorders of metabolism Splenic marginal zone B-cell lymphoma 3 Lymphoma Splenic marginal zone B-cell (+/- 80 villous lymphocy Stills disease 10 Autoimmune Disorders 3 Arthritis Subcutaneous panniculitislike T-cell lymphoma 3 Lymphoma Subcutaneous panniculitis-like T- 180 cell Synovial sarcoma 5 Solid Tumours 67 Synovial sarcoma Systemic lupus erythematosus (SLE) 10 Autoimmune Disorders 1 Connective Tissue Disease Systemic mastocytosis Systemic sclerosis 10 Autoimmune Disorders 1 Connective Tissue Disease Takatsuki disease (POEMS) 4 Plasma Cell Disorders 6 POEMS Takayasu 10 Autoimmune Disorders 2 Vasculitis EBMT 31/07/2013 Page 16 of 17
17 ification Sub- Sub-ification code T-cell granular lymphocytic leukaemia 1 Acute Leukaemia 2 ALL T-cell lymphomas (NHL), unspecified 3 Lymphoma T-CELL lymphomas (NHL), 105 unspecified Teratocarcinoma 5 Solid Tumours Teratocarcinoma (yolk sac 43 tumour) Thalassemia 11 Haemoglobinopathy 1 Thalassemia Thrombocythemia (essential / primary) Thymoma 5 Solid Tumours 91 Thymoma T-lymphocyte deficiency (CID with Ig) 8 Inherited Disorders 1 Primary immune deficiencies Ulcerative colitis 10 Autoimmune Disorders 7 Bowel Undifferentiated carcinoma 5 Solid Tumours 90 Undifferentiated carcinoma Waldenstrom 3 Lymphoma Waldenstrom 72 macroglobulinaemia Wegener granulomatosis 10 Autoimmune Disorders 2 Vasculitis Wilm tumour 5 Solid Tumours 98 Wilms tumour Wiskott Aldrich syndrome (XL) 8 Inherited Disorders 1 Primary immune deficiencies Wolman disease 8 Inherited Disorders 2 Disorders of metabolism X-linked lymphoproliferative syndrome 8 Inherited Disorders 1 Primary immune deficiencies XLP (X-linked lymphoproliferative syndrome) 8 Inherited Disorders 1 Primary immune deficiencies Yolk sac tumour 5 Solid Tumours Teratocarcinoma (yolk sac 43 tumour) EBMT 31/07/2013 Page 17 of 17
Sub-Class Code Sub-Classification Other code Other classification. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired
ification ification Other code Other classification Absence of T & B cells SCID 8 Inherited Disorders 1 Primary immune deficiencies Absence of T, normal B cell SCID 8 Inherited Disorders 1 Primary immune
Sub-Class Code Sub-Classification Other code Other classification. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired
ification Sub- Sub-ification Other code Other classification Absence of T & B cells SCID 8 Inherited Disorders 1 Primary immune deficiencies Absence of T, normal B cell SCID 8 Inherited Disorders 1 Primary
Sub-Class Code Sub-Classification Other code Other classification. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired
ification Sub- Sub-ification Other code Other classification Absence of T & B cells SCID 8 Inherited Disorders 1 Primary immune deficiencies Absence of T, normal B cell SCID 8 Inherited Disorders 1 Primary
Standard Therapies - Cord Blood
A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical
APBMT Registry LMD Disease classification sheet
AML ALL Other Acute Leukemias ACUT E LEUKEMIAS Unique Patient Number or Code: - - (yyyy - mm - dd) Classification (Check ONLY ONE): AML with recurrent genetic abnormalities Acute Lymphoblastic Leukemia
2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes
Acute basophilic leukemia 9870/3 Acute biphenotypic leukemia [OBS] 9805/3 Acute erythroid leukemia 9840/3 Acute megakaryoblastic leukemia 9910/3 Acute monoblastic and monocytic leukemia 9891/3 Acute myeloid
2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes
Malignant lymphoma, NOS 9590/3 Non-Hodgkin lymphoma, NOS 9591/3 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma 9596/3 Primary
Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint
Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic
INFORMATION KIT H PE. IS IN YOUR NEWBORN S BLOOD Help it last a lifetime with cord blood banking. Save $300 with Promo Code.
INFORMATION KIT H PE IS IN YOUR NEWBORN S BLOOD Help it last a lifetime with cord blood banking Save $300 with Promo Code Cord4Life CORD BLOOD STEM CELLS Umbilical cord blood is unique and is only available
Family Medical History Questionnaire (FMHQ)
First, Last Name DOB: Cord Blood Bank Use Only: Family Medical History Questionnaire (FMHQ) NMDP CBU ID: Local CBU ID: NMDP Maternal ID: Today's Date: Local Maternal ID: Baby's Mother's Initials: Please
Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation
Major subgroups according to the World Health Organisation (WHO) Classification Myeloproliferative neoplasms (MPN) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or
HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS
ACQUIRED ANEMIAS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are
Donating your baby s cord to a public cord blood bank can save lives globally.
Donating your baby s cord to a public cord blood bank can save lives globally. You can play an important role in saving lives by donating the blood contained in your baby s umbilical cord to LifeCord,
Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC A. LCD ID Number: L35032 Status: A-Approved
LCD for Flow Cytometry (L35032) Contractor Name: Novitas Solutions, Inc. Contractor Number: 12501 Contractor Type: MAC A LCD ID Number: L35032 Status: A-Approved Contractor Information LCD Information
The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:
Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist
CLIC Sargent Eligibility Criteria
1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd
Recommended Timing for Transplant Consultation
REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org
4000: Cellular Therapy Essential Data Pre-Infusion Form
4000: Cellular Therapy Essential Data Pre-Infusion Form Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Event date: / / CIBMTR Form 4000 revision 3 (page 1 of 19). Last
Hematology Page 1 of 8
Hematology Page 1 of 8 Hematology Major Category Code Headings Revised 12/17 1 Basic methodology and test armamentarium 20000 2 Normal hematopoiesis & hemostasis 20100 3 RBC disorders, non-neoplastic 20340
Integrated Hematopathology. Morphology and FCI with IHC
Integrated Hematopathology Morphology and FCI with IHC FrontMatter.indd i 9/6/2009 9:30:12 PM FrontMatter.indd ii 9/6/2009 9:30:18 PM Integrated Hematopathology Morphology and FCI with IHC Cherie H Dunphy,
MOC HEM - General Hematopathology (Mandatory 50-Question Module)
MOC HEM - General Hematopathology (Mandatory 50-Question Module) acute monoblastic/monocytic leukemia infectious mononucleosis adult T cell leukemia/lymphoma in situ follicular lymphoma ALL; phenotypes
MOC HEM - General Hematopathology (Mandatory 50-Question Module)
MOC HEM - General Hematopathology (Mandatory 50-Question Module) acute monoblastic/monocytic leukemia infectious mononucleosis adult T cell leukemia/lymphoma in situ follicular lymphoma ALL; phenotypes
WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia
Blood Malignancies-II Prof. Dr. Herman Hariman, a Ph.D, SpPK (KH). Prof. Dr. Adikoesoema Aman, SpPK (KH) Dept. of Clinical Pathology, School of Medicine, University of North Sumatra WHO classification
CordLife Secures US Department of Defense Contract
THEGUARDIAN Year 2004 - Eighth Issue. Mita (P) 119/11/2002 A Newsletter from CordLife CordLife Secures US Department of Defense Contract CordLife announced that its Boston-based subsidiary, Cytomatrix
Corporate Medical Policy
Corporate Medical Policy Allogeneic Hematopoietic Transplant for Genetic Diseases and File Name: Origination: Last CAP Review: Next CAP Review: Last Review: allogeneic_hematopoietic_transplant_for_genetic_diseases
HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint
HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Hematology MOC exam blueprint Based on feedback from physicians that MOC assessments should
Non-Hodgkin Lymphoma. Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract.
Non-Hodgkin Lymphoma Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract. Protocol revision date: January 2005 No AJCC/UICC staging system Procedures Cytology
12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization
Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,
Reviewing the ICD-10 classification of haematological neoplasms on its way to ICD-11
WHO-FIC NETWORK MEETING Tokyo, Japan haematological neoplasms on its way to ICD-11 Ulrich Vogel, Robert Jakob, Michael Schopen, Harald Stein, Stefan Krause Abstract: haematological neoplasms on its way
Classifications of lymphomas
Classifications of lymphomas Lukes and Collins Kiel classification Working formulation REAL classification (1994) WHO classification (2000) WHO CLASSIFICATIONF OF NEOPLASMS HAEMATOPETIC AND LYMPHOID TISSUES
Contents. vii. Preface... Acknowledgments... v xiii
Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...
MEDICAL POLICY SUBJECT: ALLOGENEIC STEM CELL TRANSPLANTATION
MEDICAL POLICY SUBJECT: ALLOGENEIC STEM CELL PAGE: 1 OF: 13 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy
Methoden / Methods inc. ICCC-3 105
Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International
SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019
SAUDI FELLOWSHIP TRAINING PROGRAM Adult Haematology Final Written Examination 2019 Examination Format: A. The Saudi fellowship specialty final written examination shall consist of one paper with 80-120
BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016
BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016 David Rice, PhD, RN, NP Director, Professional Practice
Luke Droney IMMUNOGLOBULIN LEVELS AND FUNCTION
IMMUNOGLOBULIN LEVELS AND FUNCTION Interpret changes in immunoglobulin levels within the clinical context including - Immunodeficiency - Disorders characterised by hypergammaglobulinaemia, rheumatoid arthritis,
Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER
Regence Medicare Advantage Policy Manual Policy ID: M-TRA45 Stem Cell / Bone Marrow Transplants Published: 10/01/2018 Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT
Introduction: The Revised (4 th Edition) World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues
Society for Hematopathology Scientific Symposium USCAP Companion Meeting, Boston, MA March 8, 2009 Boston, MA Steven H. Swerdlow and James Vardiman, Moderators Introduction: The Revised (4 th Edition)
Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018
Saudi Fellowship Training Program Final Written Examination of Adult Hematology 2018 Objectives: Determine the quantity and quality of a hematologist s knowledge base ranked as competent, so that the individual
Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital
Lymphoma/CLL 101: Know your Subtype Dr. David Macdonald Hematologist, The Ottawa Hospital Function of the Lymph System Lymph Node Lymphocytes B-cells develop in the bone marrow and influence the immune
National Medical Policy
National Medical Policy Subject: Policy Number: Stem Cell Transplantation in Adult Patients NMP263 Effective Date*: April 2006 Updated: June 2017 This National Medical Policy is subject to the terms in
a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation
a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral
Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. December Reference : NHSCB/B4/a/1
Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation December 2012 Reference : NHSCB/B4/a/1 NHS Commissioning Board Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation
Pediatric Hematology-Oncology
Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS
Clinical Policy: Bendamustine (Bendeka, Treanda) Reference Number: PA.CP.PHAR.307
Clinical Policy: (Bendeka, Treanda) Reference Number: PA.CP.PHAR.307 Effective Date: 01/18 Last Review Date: 11/17 Coding Implications Revision Log Description The intent of the criteria is to ensure that
Pathology of Hematopoietic and Lymphoid tissue
CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis
Pathology of Hematopoietic and Lymphoid tissue
Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph
Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham
Lymphoid Neoplasms Sylvie Freeman Department of Clinical Immunology, University of Birmingham Incidence of Haematological Malignancies UK2001 (CRUK) Malignancy New Cases All Cancers 271,000 Leukaemia 6,760
Contents SECTION 1: PHYSIOLOGY OF BLOOD
Contents SECTION 1: PHYSIOLOGY OF BLOOD Chapter 1: Overview of Physiology of Blood 1 Normal Haematopoiesis 1 Red Blood Cells 6 White Blood Cells 15 Immune System 27 Megakaryopoiesis 32 Normal Haemostasis
Medical Policy Title ALLOGENEIC HEMATOPOIETIC (STEM) CELL TRANSPLANTATION Policy Number
Page: 1 of 13 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title ALLOGENEIC HEMATOPOIETIC (STEM) CELL TRANSPLANTATION Policy Number 7.02.02 Category Transplants Effective Date 11/19/99 Revised
July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244
July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American
Immunodeficiency. By Dr. Gouse Mohiddin Shaik
Immunodeficiency By Dr. Gouse Mohiddin Shaik Immunodeficieny Immunodeficiency is failure of immune system to protect against disease or malignency Immunodeficiency is of two types Primary Secondary immunodeficiency
ASPHO 2019 Review Course January 31-February 2, 2019
ASPHO 2019 Review Course January 31-February 2, 2019 ABP Content Outline Topics by Date and Speaker For additional information, see the ABP Content Outline and the ABP Content Outline with Speaker Assignments.
CIBMTR Center Number: COPY. CIBMTR Recipient ID: Specify donor: cord blood unit. donor. unrelated donor
Recipient Baseline Data Sequence Number: Date Registry Use Only CIBMTR Center Number: Specify donor: Copy this page to report more than one donor; check here o if additional pages are attached. 1 o autologous
Changes to the Hematopoietic and Lymphoid Neoplasm Coding Manual
Changes to the Hematopoietic and Lymphoid Neoplasm Coding Manual KCR 2018 SPRING TRAINING 2018 Hematopoietic Database Updates Updates were done to the Hematopoietic Database based on the WHO Hematopoietic
Hepatic Lymphoma Diagnosis An Algorithmic Approach
Hepatic Lymphoma Diagnosis An Algorithmic Approach Ryan M. Gill, M.D., Ph.D. University of California, San Francisco PLEASE TURN OFF YOUR CELL PHONES Disclosure of Relevant Financial Relationships USCAP
HSCT - Minimum Essential Data - A REGISTRATION - DAY 0
CIC: HSCT - Minimum Essential Data - A REGISTRATION - DAY 0 Centre Identification EBMT Code (CIC): Contact person: Hospital: Email: Unit: Patient Data Date of this report: First transplant for this patient?:
incidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
Small B-cell (Histologically Low Grade) Lymphoma
Frequency of Lymphoid Neoplasms Small B-cell (Histologically Low Grade) Lymphoma Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital B-cell neoplasms 88% Diffuse large B-cell lymphoma
During past decades, because of the lack of knowledge
Staging and Classification of Lymphoma Ping Lu, MD In 2004, new cases of non-hodgkin s in the United States were estimated at 54,370, representing 4% of all cancers and resulting 4% of all cancer deaths,
Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint
Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic
What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS
What are stem cells? Stem cells are often called MASTER CELLS, and form the foundation for your entire body as building blocks for the blood, immune system, tissue and organs. They can REPLICATE or REGENERATE
Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group)
Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) January 2013 The NCIN is a UK-wide initiative, working to drive improvements in standards of cancer care and clinical outcomes by improving
Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint
Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic
Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.
SUPPLEMENTARY MATERIALS Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.0) Basket preferred term 5q minus
I. Leukemias: II. Lymphomas Hodgkin Lymphomas: Proprietary Information of Excellus Health Plan, Inc.
MEDICAL POLICY SUBJECT: AUTOLOGOUS HEMATOPOIETIC PAGE: 1 OF: 13 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
Medical Policy Title AUTOLOGOUS HEMATOPOIETIC (STEM) CELL TRANSPLANTATION Policy Number
Page: 1 of 12 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title AUTOLOGOUS HEMATOPOIETIC (STEM) CELL TRANSPLANTATION Policy Number 7.02.03 Category Transplants Effective Date 10/25/99 Revised
1. Penchansky Pediatric Bone Marrow
1. Penchansky Pediatric Bone Marrow Springer-Verlag Berlin Heidelberg GmbH Lila Penchansky Pe Bo la rle e Marrow With 356 Figures in 530 Separate Illustrations, Mostly in Color " Springer Professor LI
3.1 Introduction. It is emphasised that not all tests are necessarily required in every case. 3.2 Taxonomic structure
CHAPTER 3 CLASSIFICATION 3.1 Introduction Accurate diagnosis underpins lymphoma management. Historically, competing lymphoma classifications have been a source of frustration to pathologists, clinicians
B980 B968. C836 Diffuse non-hodgkin's lymphoma, undifferentiated (diffuse) C839 Non-follicular diffuse non-hodgkin lymphoma, unspecified
รหะส ICD ท ยกเล ก (ตาม DRG 5.1.1) รหะสท ยกเล ก Description รหะสท ใช Description A090 Other and unspecified gastroenteritis and colitis of infectious origin A09 Diarrhoea and gastroenteritis of presumed
Retired Not for Data Submission
National Marrow Donor Program Baseline and Transplant Data Unrelated Sequence Number: Date Received: Research blood samples should be collected before initiation of preparative regimen and sent to Blood
Myeloid malignancies Chronic myeloid disorders
Myeloid malignancies Chronic myeloid disorders Myeloproliferative neoplasms (MPN) Mastocytosis / Mast cell diseases Myeloid/lymphoid neoplasms with eosinophilia and gene rearrangement Myelodysplastic/myeloproliferative
THE SOCIETY FOR Hematopathology and the European
SPECIAL ARTICLE World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting Airlie House, Virginia, November
HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor
HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor I. Description of the rotation: During this rotation, the resident will gain
Common Problem Areas. WHO Classification. Defines separate diseases (entities) with their CLINICAL AGGRESSIVENESS LOW GRADE / HIGH GRADE
WHO Classification Defines separate diseases (entities) with their CLINICAL AGGRESSIVENESS REVIEW OF MOST COMMON LYMPHOMA ENTITIES Dr Stefan Dojcinov LOW GRADE / HIGH GRADE (June 2014) The Non-Hodgkin
A.C. Feller. J. Diebold Histopathology of Nodal and Extranodal Non-Hodgkin's Lymphomas
A.C. Feller. J. Diebold Histopathology of Nodal and Extranodal Non-Hodgkin's Lymphomas Springer Berlin Heidelberg New York Hong Kong London Milan Paris Tokyo Alfred C. Feller Jacques Diebold in Collaboration
Rituxan (rituximab) DRUG POLICY BENEFIT APPLICATION
DRUG POLICY BENEFIT APPLICATION Rituxan (rituximab) Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions
MP Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias
Medical Policy MP 8.01.22 BCBSA ef. Policy: 8.01.22 Last eview: 01/30/2018 Effective Date: 01/30/2018 Section: Therapy elated Policies 8.01.25 Hematopoietic Cell Transplantation for Autoimmune Diseases
Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand
Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand This list provides indications for the majority of adult BMTs that are performed in New Zealand. A small number of BMTs
Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias
Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias Policy Number: Original Effective Date: MM.07.001 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO
Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s
Non Hodgkin s Lymphoma Introduction 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Overview The types of
Classification of Hematologic Malignancies. Patricia Aoun MD MPH
Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences
The College of American Pathologists offers these protocols
Strategies for Laboratory and Patient Management Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms of the Bone Marrow A Basis for Checklists LoAnn C. Peterson, MD; Steven
HEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 6 PURPOSE To establish basic understanding of indications and contraindications for transplantation of various organs. POLICY The N.C. Department of Correction, Division of Prisons, Health Services
Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University
Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University Anemias Over 30 types Myeloproliferative Neoplasm Polycythemia Leukemia AML:M6
Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012
MEDICAL POLICY Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012 Title Allogeneic Hematopoietic Stem Cell Transplantation for Genetic Diseases and Acquired Description Hematopoietic
The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)
The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,
Lymphatic system component
Introduction Lymphatic system component Statistics Overview Lymphoma Non Hodgkin s Lymphoma Non- Hodgkin's is a type of cancer that originates in the lymphatic system. It is estimated to be the sixth most
NOTE: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material that is copyrighted by
NOTE: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material that is copyrighted by the American Medical Association. You are forbidden
LCD L Flow CytometryPrint
LCD L32562 - Flow CytometryPrint Contractor Information Contractor Name: Novitas Solutions, Inc. Contractor Number(s): 12501, 12101, 12102, 12201, 12202, 12301, 12302, 12401, 12402, 12901, 12502 Contractor
3/5/2013. Hematopoiesis: Red and white marrow. Hematopoiesis. Bone marrow aspirate and core biopsy. Gartner, Color Textbook of Histology, 3 rd Edition
Hematopoiesis Hematopoiesis: Red and white marrow Bone marrow aspirate and core biopsy Gartner, Color Textbook of Histology, 3 rd Edition 1 reticulocytes elliptocytes schistocytes spheroctyes target cells
STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry)
STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry) 1 1 No. Patient Name Diseases Transplant Centers Cord Blood Volume in ml 1 Patient 1 RELAPSED BILINEAGE LEUKEMIA HLA match
oimmune_disease
http://en.wikipedia.org/wiki/aut oimmune_disease Autoimmune diseases arise from an overactive immune response of the body against substances and tissues normally present in the body. In other words, the
Clinical Policy: Bendamustine (Bendeka, Treanda) Reference Number: CP.PHAR.307
Clinical Policy: (Bendeka, Treanda) Reference Number: CP.PHAR.307 Effective Date: 02/17 Last Review Date: 02/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important
UnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 1090-7 Program Prior Authorization/Notification Medication Revlimid (lenalidomide) P&T Approval Date 6/2009, 3/2010, 6/2010, 9/2010,
88-year-old Female with Lymphadenopathy. Faizi Ali, MD
88-year-old Female with Lymphadenopathy Faizi Ali, MD Clinical History A 88-year-old caucasian female presented to our hospital with the complaints of nausea, vomiting,diarrhea, shortness of breath and